Mer­ck cough drug fails to win ad­comm’s back­ing as FDA rais­es ef­fi­ca­cy ques­tions

The FDA’s Pul­monary-Al­ler­gy Drugs Ad­vi­so­ry Com­mit­tee vot­ed 12 to 1 in sup­port of re­ject­ing Mer­ck’s ap­pli­ca­tion for its chron­ic cough drug gefapix­ant, fol­low­ing agency …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER